Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL804112 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTHRBHSD17B10GAA | |
| SCHEMBL24388708 | 0.98 | TSHR (0.50) | ALDH1A1TSHRTHRBHSD17B10GAA | |
| SCHEMBL20711104 | 0.85 | TSHR (0.48) | ALDH1A1TSHRTHRBHSD17B10GAA | |
| SCHEMBL12392808 | 0.82 | MEN1 (0.42) | ALDH1A1TSHRTHRBHSD17B10CYP4F2 | |
| SCHEMBL20469685 | 0.82 | TSHR (0.35) | ALDH1A1TSHRHSD17B10CYP4F2CYP4A11 | |
| SCHEMBL20469651 | 0.82 | TSHR (0.35) | ALDH1A1TSHRHSD17B10CYP4F2CYP4A11 | |
| SCHEMBL12392809 | 0.82 | TSHR (0.35) | ALDH1A1TSHRHSD17B10CYP4F2CYP4A11 | |
| SCHEMBL803570 | 0.81 | GRM1 (0.38) | ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL803788 | 0.81 | GRM1 (0.38) | ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL12392803 | 0.81 | MEN1 (0.32) | ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785655-B2 | Ionic liquid solvents | DUBLIN CITY UNIVERSITY (IE) | 2014-07-22 | — | — | US | disclosed |
| US-20120071661-A1 | Ionic Liquid Solvents | DUBLIN CITY UNIVERSITY (IE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071661-A1 | Ionic Liquid Solvents | EBP, PAICS, HACD3 | ALDH1A1 834/4885TSHR 4680/4885THRB 2543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.